[The antibacterial and chemotherapeutic activity of the Soviet produced antibiotic rifamitsina SV].
D000818:Animals; D001424:Bacterial Infections / Q000188:drug therapy*; D001884:Bordetella / Q000187:drug effects; D004917:Erythromycin / Q000627:therapeutic use; D004926:Escherichia coli / Q000187:drug effects; D004927:Escherichia coli Infections / Q000188:drug therapy; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007231:Infant, Newborn; D007711:Klebsiella pneumoniae / Q000187:drug effects; D008034:Lincomycin / Q000627:therapeutic use; D008089:Listeria monocytogenes / Q000187:drug effects; D051379:Mice; D011008:Pneumococcal Infections / Q000188:drug therapy; D011511:Proteus / Q000187:drug effects; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D012294:Rifamycins / Q000494:pharmacology* / Q000627:therapeutic use; D012505:Sarcina / Q000187:drug effects; D018805:Sepsis / Q000188:drug therapy; D013203:Staphylococcal Infections / Q000188:drug therapy; D013210:Staphylococcus / Q000187:drug effects; D013290:Streptococcal Infections / Q000188:drug therapy; D013291:Streptococcus / Q000187:drug effects; D013296:Streptococcus pneumoniae / Q000187:drug effects
D012294:Rifamycins; D004917:Erythromycin; D008034:Lincomycin
Izuchenia antibakterial'noĭ i khimioterapevticheskoĭ aktivnosti antibiotika rifamitsina SV otechestvennogo proizvodstva